Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histidine protein methyltransferase 1 homolog (METTL18) is a protein methyltransferase that specifically methylates histidine 245 on the ribosomal protein RPL3[1]. This τ-N-methylation modification of RPL3 slows translation elongation specifically at tyrosine codons, ensuring nascent protein folding and maintenance of proteome quality, particularly by protecting cells against aggregation of tyrosine-rich proteins. METTL18 functions primarily as a translational modulator and quality control factor, and altered function or expression of this enzyme may play a role in diseases such as cancer by disturbing protein homeostasis[1][2].
Catalyzes τ-N-methylation of histidine 245 on RPL3, modifying ribosomal function[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histidine protein methyltransferase 1 homolog (METTL18).